$CRWDNeutralLow

GANDHI SAMEER K sold $9K of CRWD (indirect holdings)

GANDHI SAMEER K sold 12 indirectly-held shares of CrowdStrike Holdings, Inc. (CRWD) at $744.98 on 2026-06-01 under a Rule 10b5-1 trading plan.

3/10
3/10
Low
Neutral
Filed today; sale executed 2026-06-01 under a 10b5-1 plan.
Neutral—insider selling is disclosed but appears routine and small.

Small, pre-arranged insider sale provides limited fundamental signal; mainly a flow/positioning datapoint.

CrowdStrike director Sameer K. Gandhi sold ~$8.9K of CRWD shares via an open-market transaction under a 10b5-1 plan.

Likely negligible near-term price impact; watch for any follow-on insider activity or plan changes.

Background

SEC Form 4 reports insider transactions; Rule 10b5-1 sales are pre-scheduled to mitigate timing-based trading concerns.

Why it matters

The disclosure updates insider activity records but does not introduce new company fundamentals (no earnings, guidance, deal, or legal/regulatory event).

Market relevance

Primarily a routine insider-flow datapoint; limited expected impact on valuation or risk.

Market effects

No clear sector read-through; this is company-specific insider disclosure without new operational/regulatory catalyst.

None.

None.

Alternative perspectives

Even small 10b5-1 sales can coincide with internal expectations; traders may still treat it as a minor sentiment headwind if multiple insiders sell around the same window.

The transaction size is very small and the plan is pre-arranged, so the signal-to-noise for directional trading is low.

Key entities

  • CrowdStrike Holdings, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • GANDHI SAMEER K

    Director who sold CRWD shares under a 10b5-1 plan.

Related articles

$CRWDMed

Weakness May Be an Opportunity for CrowdStrike Stock

CrowdStrike said demand for its Falcon platform and broader security offerings remains strong as cybersecurity spending grows, including amid AI adoption, according to management. The company raised full-year ARR guidance to $6.53B–$6.56B and increased revenue and earnings guidance. Analysts: 34 “Strong Buy,” 3 “Moderate Buy,” 11 “Hold,” 2 “Strong Sell” (consensus “Moderate Buy”); mean target $723.74 and high $825.

$ZSMedAI 9/10

Cybersecurity Earnings: 1 AI Standout and 2 Stocks Under Pressure

Zscaler shares fell more than 31% after fiscal Q3 2026 results, despite revenue of $850M+ (+25% YoY vs. $835M est.) and adjusted EPS of $1.08 (+28% YoY vs. $1.01 est.). The company raised full-year revenue growth to 24.6%–24.7% but cut its free-cash-flow margin outlook (midpoint 26.75% to 23.1%) and guided 16%–17% ARR growth next year. CrowdStrike slipped about 7% after fiscal Q1 2027 beats and a raise; revenue was $1.39B (+26% YoY), EPS $1.10 (+51% YoY), and net new ARR growth guidance increase

$CRWDLow

Rosenblatt Lifts PT on CrowdStrike (CRWD) Following “Outstanding” Q1

Rosenblatt raised its CrowdStrike (CRWD) price target to $825 from $640 and kept a Buy rating after what it called an “outstanding” fiscal Q1. The firm said shares fell about 11% after hours, attributing it to profit taking after an ~87% post-earnings rise, and cited the “Mythos moment” and Falcon’s role in AI cybersecurity. Wedbush also raised its target to $720 from $700, maintaining Outperform.

$CRWDLow

Is CrowdStrike Stock a Buy on the Dip?

CrowdStrike shares fell after fiscal Q1 results, despite the company raising its full-year ARR growth outlook to 27%–29% from 23%–24%, according to the report. Ending ARR rose 24% to $5.51B and net new ARR 32% to $256M. Revenue grew 26% to $1.39B; adjusted EPS rose 51% to $1.10. Fiscal 2027 revenue guidance was $5.915B–$5.959B and adjusted EPS $4.88–$4.96.